Equity Capital Markets

All filings · since 4 November 2002

Filings

Every share-offering filing on EDGAR since the day foreign issuers also had to file electronically. One row per filer: a filing made by a parent and its subsidiaries appears once for each of them, as in SEC's own index.

Page 1 · newest first · 50 per pageDownload as CSV (up to 5,000 rows)
FiledCompanyFilingAccession
2025-10-15
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-25-240259
2025-05-19
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0000950170-25-074553
2024-08-05
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 S-3ASRShelf registered0000950123-24-007171
2024-02-13
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-24-032975
2021-07-29
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 S-3ASRShelf registered0001193125-21-229395
2021-01-15
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-21-010074
2020-12-11
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-20-315407
2020-07-01
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-20-185304
2020-06-29
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-20-182373
2019-11-21
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-19-297588
2019-11-19
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-19-295571
2019-08-30
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-19-235292
2018-11-09
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-18-322757
2018-09-24
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-18-281365
2018-09-21
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-18-279998
2018-09-19
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-18-277609
2018-09-19
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 S-3ASRShelf registered0001193125-18-277572
2018-08-31
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-18-265001
2018-01-05
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-18-004567
2018-01-03
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 424B5Shelf takedown0001193125-18-000978
2017-12-04
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 EFFECTDeclared effective9999999995-17-003132
2017-11-09
CRISPR Therapeutics AG
ShelfEffectiveCIK 1674416
 S-3Shelf registered0001193125-17-339033
2016-10-19
CRISPR Therapeutics AG
IPOFinal prospectusCIK 1674416
 424B4Final prospectus0001193125-16-741812
2016-10-18
CRISPR Therapeutics AG
IPOFinal prospectusCIK 1674416
 EFFECTDeclared effective9999999995-16-005999
2016-10-14
CRISPR Therapeutics AG
IPOFinal prospectusCIK 1674416
 S-1/AAmendment0001193125-16-738437
2016-10-07
CRISPR Therapeutics AG
IPOFinal prospectusCIK 1674416
 S-1/AAmendment0001193125-16-733213
2016-09-09
CRISPR Therapeutics AG
IPOFinal prospectusCIK 1674416
 S-1Registration filed0001193125-16-706569
2016-05-13
CRISPR Therapeutics AG
CIK 1674416
 DRSDraft made public0000950123-16-017103